Distinct roles of Mdm2 and Mdm4 in red cell production

被引:57
作者
Maetens, Marion
Doumont, Gilles
De Clercq, Sarah
Francoz, Sarah
Froment, Pascal
Bellefroid, Eric
Klingmuller, Ursula
Lozano, Guillermina
Marine, Jean-Christophe
机构
[1] Univ Ghent VIB, Flanders Inst Biotechnol, Lab Mol Canc Biol, B-9052 Ghent, Belgium
[2] Free Univ Brussels VIB, Mol Embryol Lab, Gosselies, Belgium
[3] German Canc Res Ctr, D-6900 Heidelberg, Germany
[4] Univ Texas, MD Anderson Canc Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA
[5] Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Sect Canc Genet, Houston, TX 77030 USA
关键词
D O I
10.1182/blood-2006-03-013656
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mdm2 and Mdm4 are critical negative regulators of the p53 tumor suppressor. Mdm4-null mutants are severely anemic and exhibit impaired proliferation of the fetal liver erythroid lineage cells. This phenotype may indicate a cell-intrinsic function of Mdm4 in erythropoiesis. In contrast, red blood cell count was nearly normal in mice engineered to express low levels of Mdm2, suggesting that Mdm2 might be dispensable for red cell production. Here, we further explore the tissue-specific functions of Mdm2 and Mdm4 in the erythroid lineage by intercrossing conditional Mdm4 and Mdm2 alleles to an erythroid-specific Cre (Er-GFP-Cre) knock-in allele. Our data show that Mdm2 is required for rescuing erythroid progenitors from p53-mediated apoptosis during primitive erythropoiesis. In contrast, Mdm4 is only required for the high erythropoietic rate during embryonic definitive erythropoiesis. Thus, in this particular cellular context, Mclm4 only contributes to p53 regulation at a specific phase of the differentiation program.
引用
收藏
页码:2630 / 2633
页数:4
相关论文
共 50 条
[41]   Double knockdown of MDM4 and MDM2 modulates the antitumor effects of cytotoxic drugs in colon and gastric cancer cells expressing high levels of MDM4 [J].
Imanishi, Mamiko ;
Yamamoto, Yoshiyuki ;
Endo, Shinji ;
Yamato, Kenji ;
Hyodo, Ichinosuke .
CANCER RESEARCH, 2019, 79 (13)
[42]   Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4 [J].
J-C Marine ;
S Francoz ;
M Maetens ;
G Wahl ;
F Toledo ;
G Lozano .
Cell Death & Differentiation, 2006, 13 :927-934
[43]   MDM2和MDM4对P53调控研究进展 [J].
赵婧 ;
屈艺 ;
母得志 .
医学研究杂志, 2011, 40 (10) :141-143
[44]   The p53 Negative Regulator, MDM4 but Not MDM2, Is Frequently Activated in Hepatocellular Carcinoma [J].
Zhou, X. ;
Bloomston, M. ;
Shirley, L. A. ;
Lozanski, A. ;
Lozanski, G. ;
Frankel, W. L. .
LABORATORY INVESTIGATION, 2013, 93 :413A-413A
[45]   Tumor-specific signaling to p53 is mimicked by Mdm2 inactivation in zebrafish: insights from mdm2 and mdm4 mutant zebrafish [J].
J S Chua ;
H P Liew ;
L Guo ;
D P Lane .
Oncogene, 2015, 34 :5933-5941
[46]   miR-661 downregulates both Mdm2 and Mdm4 to activate p53 [J].
Hoffman, Y. ;
Bublik, D. R. ;
Pilpel, Y. ;
Oren, M. .
CELL DEATH AND DIFFERENTIATION, 2014, 21 (02) :302-309
[47]   Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability [J].
Pant, Vinod ;
Xiong, Shunbin ;
Iwakuma, Tomoo ;
Quintas-Cardama, Alfonso ;
Lozano, Guillermina .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (29) :11995-12000
[48]   miR-661 downregulates both Mdm2 and Mdm4 to activate p53 [J].
Y Hoffman ;
D R Bublik ;
Y Pilpel ;
M Oren .
Cell Death & Differentiation, 2014, 21 :302-309
[49]   Analysis of MDM2 and MDM4 Single Nucleotide Polymorphisms, mRNA Splicing and Protein Expression in Retinoblastoma [J].
McEvoy, Justina ;
Ulyanov, Anatoly ;
Brennan, Rachel ;
Wu, Gang ;
Pounds, Stanley ;
Zhang, Jinghui ;
Dyer, Michael A. .
PLOS ONE, 2012, 7 (08)
[50]   The p53 Negative Regulator, MDM4 but Not MDM2, Is Frequently Activated in Hepatocellular Carcinoma [J].
Zhou, X. ;
Bloomston, M. ;
Shirley, L. A. ;
Lozanski, A. ;
Lozanski, G. ;
Frankel, W. L. .
MODERN PATHOLOGY, 2013, 26 :413A-413A